IL113346A - Method to identify immunocompromised patients at high risk for cryptococcosis - Google Patents

Method to identify immunocompromised patients at high risk for cryptococcosis

Info

Publication number
IL113346A
IL113346A IL11334695A IL11334695A IL113346A IL 113346 A IL113346 A IL 113346A IL 11334695 A IL11334695 A IL 11334695A IL 11334695 A IL11334695 A IL 11334695A IL 113346 A IL113346 A IL 113346A
Authority
IL
Israel
Prior art keywords
cryptococcosis
high risk
identify
immunocompromised patients
glucuronoxylomannan
Prior art date
Application number
IL11334695A
Other languages
English (en)
Other versions
IL113346A0 (en
Original Assignee
Res Dev Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Res Dev Foundation filed Critical Res Dev Foundation
Publication of IL113346A0 publication Critical patent/IL113346A0/xx
Publication of IL113346A publication Critical patent/IL113346A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/544—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being organic
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/544—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being organic
    • G01N33/545—Synthetic resin
    • G01N33/547—Synthetic resin with antigen or antibody attached to the carrier via a bridging agent
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
IL11334695A 1994-05-02 1995-04-12 Method to identify immunocompromised patients at high risk for cryptococcosis IL113346A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/236,331 US5677137A (en) 1994-05-02 1994-05-02 Method to identify immunocompromised patients at high risk for cryptococcosis

Publications (2)

Publication Number Publication Date
IL113346A0 IL113346A0 (en) 1995-07-31
IL113346A true IL113346A (en) 2000-01-31

Family

ID=22889066

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11334695A IL113346A (en) 1994-05-02 1995-04-12 Method to identify immunocompromised patients at high risk for cryptococcosis

Country Status (15)

Country Link
US (1) US5677137A (xx)
EP (1) EP0758375B1 (xx)
JP (1) JPH09512909A (xx)
KR (1) KR970702928A (xx)
CN (1) CN1147270A (xx)
AT (1) ATE244298T1 (xx)
AU (1) AU690686B2 (xx)
CA (1) CA2189470A1 (xx)
DE (1) DE69531206D1 (xx)
IL (1) IL113346A (xx)
NZ (1) NZ285264A (xx)
RU (1) RU2156619C2 (xx)
TW (1) TW350913B (xx)
WO (1) WO1995029985A1 (xx)
ZA (1) ZA953432B (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105784987A (zh) * 2016-02-29 2016-07-20 丹娜（天津）生物科技有限公司 一种新型隐球菌荚膜多糖gxm的制备方法
CN111234044B (zh) * 2020-01-19 2021-04-27 广西中医药大学 一种低分子量金耳葡糖醛酸-木甘聚糖及其制备方法和应用

Also Published As

Publication number Publication date
AU2431095A (en) 1995-11-29
ATE244298T1 (de) 2003-07-15
US5677137A (en) 1997-10-14
NZ285264A (en) 1997-11-24
WO1995029985A1 (en) 1995-11-09
EP0758375A4 (en) 1997-11-26
EP0758375A1 (en) 1997-02-19
AU690686B2 (en) 1998-04-30
KR970702928A (ko) 1997-06-10
ZA953432B (en) 1996-10-28
IL113346A0 (en) 1995-07-31
TW350913B (en) 1999-01-21
RU2156619C2 (ru) 2000-09-27
CA2189470A1 (en) 1995-11-09
DE69531206D1 (de) 2003-08-07
CN1147270A (zh) 1997-04-09
JPH09512909A (ja) 1997-12-22
EP0758375B1 (en) 2003-07-02

Similar Documents

Publication Publication Date Title
NO20092994L (no) Anvendelse av et monoklonalt eller polyklonalt antistoff, fremgangsmate og kit for in vitro diagnose samt fremgangsmate for a identifisere og/eller isolere midler
IL143892A0 (en) Kidney disease detection and treatment
DE60228557D1 (de) Candida-nachweis
AU7260496A (en) A method and diagnostic test kit for use in aiding the diagnosis of fibromyyalgia and chronic fatigue syndrome (CFS)
DK0648335T3 (da) Diagnostisk fremgangsmåde til bestemmelse af fødselstilbøjeligheden og reagenskit til anvendelse dertil
ATE285581T1 (de) Assay-verfahren
AU2002233800A1 (en) Method and kit for predicting cancer
IL113346A0 (en) Method to identify immunocompromised patients at high risk for cryptococcosis
EP0906574A4 (en) ENDOTOXIN IDENTIFICATION METHODS AND KITS
NZ306622A (en) Method for diagnosing a patient for chlamydia
AU2696495A (en) Method for determining hiv-1 antigen and antibody
ES2175123T3 (es) Procedimiento que sirve para determinar la concentracion de oxigeno enuna muestra.
CA2398477A1 (en) Methods for determining risk of developing cervical cancer
EP1052511A4 (en) CROHN'S DISEASE SCREENING METHOD AND ANALYSIS KIT PROVIDED THEREFOR
CA2346406A1 (en) Detection of pleiotrophin
KR930700548A (ko) 자궁내막 항체 측정방법 및 측정용 자궁내막 항원, 조성물, 테스트킷
PT672756E (pt) Anticorpo monoclonal que reconhece a proteina de ligacao a fk506 processo de doseamento do nivel de proteina de ligaca a fk506 e "kit" para doseamento
ZA944024B (en) Immunoassay reagents and methods for detecting brequinar and analoges
ES2001626A6 (es) Metodo para diagnosis inmunoquimica relacioonado con prosomas .
ES2184109T3 (es) Determinacion de analitos mediando utilizacion de dos marcaciones.
DE69526056D1 (de) Immunologisches Testverfahren zur Quantifizierung von PEG-modifiziertem humanem Granulozyten-Kolonie-Stimulierender-Faktor
ATE228249T1 (de) Immuntest zum nachweis von menschlichen cytomegalovirus spezifischen igm
EP0788595A4 (en) METHOD FOR TESTING IMMUNOCOMPETENCY
NO964803D0 (no) Fremgangsmåte for måling av konsentrasjonen av glykoler/polyglykoler i fluiden, måleinstrument samt analysesett
IT1309442B1 (it) Procedimento di rivelazione immunoenzimatica di un complesso antigene/anticorpo primario e kit diagnostico per la sua attuazione.

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees